Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Branded Interim - 1 June 2026

NHS England

This public procurement record has 6 releases in its history.

Award

22 May 2026 at 14:11

UK7 - Contract Details Notice
Award

16 Apr 2026 at 16:01

UK6 - Contract Award Notice
Tender

03 Feb 2026 at 15:04

UK4 - Tender Notice
PlanningUpdate

29 Dec 2025 at 11:36

UK2 - Preliminary Market Engagement Notice
PlanningUpdate

23 Dec 2025 at 11:25

UK2 - Preliminary Market Engagement Notice
Planning

22 Dec 2025 at 14:59

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS England has concluded its procurement process for the NHS National Branded Interim contract, covering the period from 1 June 2026 to 30 April 2028, with potential extensions up to a total of 25 months. This open procedure tender, focusing on pharmaceutical products, has culminated in active contracts with several suppliers including Aspire Pharma Limited and Novartis Pharmaceuticals UK Limited to provide goods across various UK regions. The contract is valued at £634,908,936 gross and reflects NHS England's effort to bolster its pharmaceutical supply chain through a competitive process that included 53 valid bids. This contract agreement took effect on 1 June 2026 following its award in May and is part of a strategic framework agreement with the possibility for competition reopening among selected suppliers.

This tender presents a substantial business opportunity for companies within the pharmaceutical industry, particularly those with the capability to deliver a wide range of branded medical products. The potential for business growth is significant due to the large-scale supply requirements across multiple UK regions. SMEs, in particular, have been actively considered, as reflected in the number of small and medium-sized enterprises participating in the bids. Thus, companies that specialize in pharmaceutical manufacturing or distribution and seek to expand their footprint in public sector procurement, especially within healthcare, would benefit immensely from engaging in such contractual opportunities provided by NHS England.

How relevant is this notice?

Notice Information

Notice Title

NHS National Branded Interim - 1 June 2026

Notice Description

Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

Lot Information

Lot 1

Options: With an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 25 months.

Renewal: 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

Planning Information

Preliminary market engagement in relation to the upcoming tender for the NHS National Framework Agreement for the supply of National Branded and Branded Generic Products. The purpose of the preliminary market engagement is for supplier feedback on the product listing (list can be subject to change) and to ensure suppliers are aware of the requirements to participate in the framework. Please note NHS England is utilising an electronic system (Atamis) to manage this RFI and communicate with suppliers. Accordingly, there will be no hard copy documents issued to suppliers and all communications with NHS England including the submission of RFI responses will be conducted via Atamis using the following link: https://health-family.force.com/login If not already registered, please create an Atamis account using this link https://health-family.force.com/login Please note there is no fee for registering on Atamis. If you experience any technical issues, then support from Atamis can be obtained here: 1. Submit a request through the Atamis Help Centre 2. Email directly at support-health@atamis.co.uk 3. Call support on 0800 0988 201 08:00-18:00 Monday - Friday Upon logging in please search for C409236 "National Branded Interim - 1st June 2026 and follow the instructions contained in the supplier instructions.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05fbbc
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/047944-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,346,663,020 £1B-£10B
Lots Value
£1,346,663,020 £1B-£10B
Awards Value
£529,090,780 £100M-£1B
Contracts Value
£529,090,780 £100M-£1B

Notice Dates

Publication Date
22 May 20263 months ago
Submission Deadline
6 Mar 2026Expired
Future Notice Date
9 Feb 2026Expired
Award Date
10 Apr 20264 months ago
Contract Period
1 Jun 2026 - 30 Apr 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
51
Supplier Names

ACCORD-UK LTD

ASCEND LABORATORIES (UK) LIMITED

ASPIRE PHARMA LIMITED

ASTRAZENECA UK LIMITED

AVENTIS PHARMA LIMITED

CAMURUS AB

CIPLA (EU) LIMITED

CONSILIENT HEALTH (UK) LIMITED

CST PHARMA LIMITED

DAY LEWIS MEDICAL LIMITED

ESSENTIAL PHARMA LIMITED

ESTEVE PHARMACEUTICALS LTD

EUMEDICA PHARMA LTD

FLEXIPHARM AUSTRADING LIMITED

FLYNN PHARMA LIMITED

GLENMARK PHARMACEUTICALS EUROPE LIMITED

GRUNENTHAL LIMITED

JANSSEN-CILAG LIMITED

LOGIXX PHARMA LIMITED

LUPIN HEALTHCARE (UK) LIMITED

MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED)

MEDAC PHARMA LLP

MERCK SHARP & DOHME (UK) LIMITED

MERCURY PHARMACEUTICALS LIMITED

MORNINGSIDE PHARMACEUTICALS LIMITED

MSN LABORATORIES EUROPE LIMITED

NAPP PHARMACEUTICALS LIMITED

NEURAXPHARM UK LIMITED

NORDIC PHARMA LIMITED

NORGINE PHARMACEUTICALS LIMITED

NOVARTIS PHARMACEUTICALS UK LIMITED

ORPHALAN UK LTD

PFIZER LIMITED

RENASCIENCE PHARMA LIMITED

ROSEMONT PHARMACEUTICALS LIMITED

SANTEN UK LIMITED

SELECTIVE SUPPLIES LIMITED

SERB LTD

STIRLING ANGLIAN PHARMACEUTICALS LIMITED

SUN PHARMA UK LIMITED

SWEDISH ORPHAN BIOVITRUM LTD

SYNCHRONY (CNX THERAPEUTICS LIMITED)

SYRI LIMITED

TAKEDA UK LIMITED

TEVA UK LIMITED

THEA PHARMACEUTICALS LIMITED

THORNTON & ROSS LIMITED

UNICORN PHARMACEUTICALS LIMITED

VIATRIS UK HEALTHCARE LIMITED (MYLAN)

ZENTIVA PHARMA UK LIMITED

ZYDUS PHARMACEUTICALS UK LTD

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...